Saturday 17 October 2026
Export GH’s income statement to Excel — free account
Guardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024. In the quarter to June 2026, revenue grew 44.3%, EPS fell 12.5%, free cash flow fell 5.46% and total debt rose 34.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
158.29
7.59
−4.58%
Follow GH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 4 | 4 | 3 | 1 | 3 | 4 | — | — | — |
Altman Z-Score |
2.02 | (0.86) | (0.52) | (0.46) | 3.31 | 8.09 | 25.96 | 6.40 | — | — |
P/S ratio |
13.04 | 5.07 | 5.26 | 6.14 | 27.12 | 43.83 | 33.02 | 12.61 | 5.88 | 5.88 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(2.57) | (4.09) | (1.74) | (1.53) | 0.43 | 5.04 | 6.91 | 6.96 | 10.35 | — |
Beneish M-Score |
(2.78) | (2.88) | (2.74) | (3.81) | (1.52) | (3.76) | (1.40) | (1.76) | — | — |
P/Operating CF |
(485.56) | (58.13) | (37.71) | (30.40) | (131.62) | (212.19) | (233.32) | (43.06) | (18.38) | (18.38) |
P/B ratio |
0.00 | 0.00 | 18.71 | 45.84 | 15.71 | 9.68 | 8.87 | 2.37 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 20.28 | 61.09 | 16.15 | 9.82 | 9.08 | 2.40 | 0.00 | 0.00 |
EV/Sales |
13.35 | 5.48 | 5.21 | 6.42 | 27.66 | 40.38 | 30.77 | 7.99 | 1.94 | 1.94 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(70.95) | (16.90) | (9.05) | (9.32) | (49.45) | (111.40) | (139.95) | (10.03) | (2.10) | (2.10) |
EV/FCF |
(52.23) | (13.84) | (8.09) | (7.13) | (34.23) | (73.28) | (100.17) | (7.84) | (1.60) | (1.60) |
Quick Ratio |
4.42 | 4.21 | 6.11 | 5.74 | 5.29 | 27.66 | 7.85 | 9.69 | 11.93 | 7.00 |
Current Ratio |
4.84 | 4.68 | 6.54 | 6.17 | 5.72 | 28.27 | 8.21 | 9.99 | 12.38 | 7.36 |
Net Debt/EBITDA |
(0.75) | (0.74) | 0.05 | (0.25) | (0.54) | 4.30 | 6.59 | 4.78 | 3.11 | 1.96 |
Debt/Assets |
74.69% | 76.91% | 63.81% | 70.65% | 51.48% | 35.49% | 4.16% | 1.19% | 0.13% | 0.00% |
Debt/Equity |
(15.14) | (8.18) | 7.18 | 18.90 | 1.76 | 0.62 | 0.05 | 0.01 | 0.00 | 0.00 |
Asset Turnover |
0.56 | 0.45 | 0.33 | 0.24 | 0.17 | 0.18 | 0.28 | 0.19 | 0.29 | 0.15 |
Operating CF/Net income |
0.44 | 0.55 | 0.68 | 0.47 | 0.52 | 0.41 | 0.62 | 0.85 | 0.81 | 0.80 |
Capex/Depreciation |
(1.43) | (0.99) | (0.70) | (1.80) | (1.99) | (2.18) | (2.33) | (3.00) | (1.20) | (0.44) |
Interest Coverage |
(112.20) | (171.87) | (219.06) | (211.24) | (159.49) | (53.49) | (69.75) | (74.29) | (28.35) | (14.53) |
| 348.42% | (4,584.50%) | (438.13%) | (185.65%) | (41.75%) | (24.21%) | (11.81%) | (58.31%) | 61.09% | 31.71% | |
| (23.79%) | (26.67%) | (28.23%) | (34.32%) | (18.13%) | (15.69%) | (9.76%) | (18.29%) | (51.90%) | (26.90%) | |
ROIC |
(134.56%) | (170.17%) | (271.47%) | (182.59%) | (30.32%) | (51.42%) | (16.31%) | (81.60%) | (54.57%) | 0.00% |
Return on Tangible Assets |
(31.80%) | (45.16%) | (37.27%) | (56.13%) | (38.86%) | (13.47%) | (13.31%) | (18.78%) | (37.18%) | (45.23%) |
Average Days of Receivables |
51.24 | 54.45 | 57.46 | 78.97 | 95.39 | 67.85 | 81.70 | 143.72 | 93.64 | 43.37 |
Research and Development Expense of Revenue |
37.09% | 47.06% | 65.11% | 83.15% | 70.45% | 52.27% | 40.25% | 55.95% | 51.29% | 43.01% |
Selling, General and Administrative Expense of Revenue |
71.90% | 73.75% | 79.98% | 103.17% | 106.66% | 104.38% | 65.18% | 98.92% | 138.99% | 143.03% |
Intangible Assets out of Total Assets |
0.05 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.03 | 0.00 |
Share Based Compensation of Revenue |
16.93% | 19.00% | 16.09% | 21.06% | 40.53% | 50.26% | 7.91% | 7.56% | 7.36% | 7.81% |
Graham Net Nets |
(0.05) | (0.15) | (0.09) | (0.13) | (0.04) | 0.07 | 0.06 | 0.32 | 0.51 | 0.51 |
Graham Number |
7.68 | 9.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(3.24%) | (11.65%) | (16.14%) | (23.70%) | (4.00%) | (2.00%) | (1.07%) | (13.70%) | (22.41%) | (22.41%) |
Free Cash Flow Yield |
(1.96%) | (7.81%) | (12.24%) | (14.67%) | (2.98%) | (1.26%) | (0.93%) | (8.08%) | (20.70%) | (20.70%) |
Revenue per Share |
7.83 | 6.02 | 5.04 | 4.40 | 3.69 | 2.94 | 2.37 | 2.98 | 3.96 | 1.93 |
Operating CF per Share |
(1.47) | (1.95) | (2.90) | (3.03) | (2.06) | (1.07) | (0.52) | (2.37) | (5.74) | (2.81) |
Capex per Share |
(0.39) | (0.29) | (0.18) | (0.76) | (0.74) | (0.55) | (0.23) | (0.66) | (0.53) | (0.14) |
Free Cash Flow per Share |
(1.86) | (2.24) | (3.08) | (3.79) | (2.80) | (1.62) | (0.75) | (3.04) | (6.27) | (2.95) |
Cash per Share |
9.58 | 6.84 | 10.44 | 9.90 | 9.21 | 18.41 | 5.77 | 13.78 | 17.59 | 7.28 |
Shareholders Equity per Share |
(0.79) | (1.14) | 1.42 | 0.59 | 6.37 | 13.32 | 8.81 | 15.89 | 24.53 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.79) | (1.14) | 1.42 | 0.59 | 6.37 | 13.32 | 8.81 | 15.89 | 24.53 | 0.00 |
Free Cash Flow |
(233.07) | (274.94) | (345.46) | (386.92) | (284.05) | (157.99) | (68.35) | (92.39) | (78.92) | (38.48) |
Working Capital |
1,163.32 | 829.53 | 1,141.19 | 998.37 | 919.44 | 1,821.55 | 524.62 | 422.05 | 223.31 | 89.00 |
Capital Expenditures |
(48.31) | (35.08) | (20.49) | (77.46) | (75.03) | (54.06) | (21.22) | (20.20) | (6.68) | (1.77) |
Net Current Asset Value |
(646.92) | (570.14) | (280.63) | (358.21) | (445.37) | 915.08 | 433.22 | 364.74 | 208.60 | 103.00 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.05 | 0.04 | 0.17 | 0.20 | 0.19 | 0.10 | 0.22 | 0.13 | 0.07 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | 0.26 | 0.20 | 0.26 | 0.30 | 0.40 | 0.21 | 0.22 | 0.35 | 0.31 |
Cash ROIC |
(8.94%) | (14.92%) | (14.00%) | (17.52%) | (10.47%) | (4.05%) | (5.02%) | (10.16%) | (14.88%) | (34.35%) |
Accounts Receivable Turnover |
7.92 | 7.43 | 6.06 | 4.61 | 4.95 | 5.66 | 5.12 | 3.74 | 6.31 | 3.16 |
Accounts Payable Turnover |
7.51 | 6.42 | 2.00 | 1.11 | 2.18 | 7.86 | 5.27 | 5.53 | 7.91 | 5.53 |
Inventory Turnover |
4.45 | 4.36 | 4.00 | 3.80 | 4.60 | 4.88 | 5.82 | 5.26 | 6.15 | 4.42 |
Average Days of Payables |
56.94 | 48.55 | 83.18 | 410.51 | 312.88 | 28.95 | 83.60 | 89.89 | 57.70 | 49.49 |
Days of Inventory on Hand |
89.81 | 89.53 | 99.59 | 120.48 | 91.09 | 89.60 | 78.35 | 77.17 | 84.12 | 49.49 |
Average Receivables |
124.05 | 99.52 | 93.02 | 97.45 | 75.48 | 50.64 | 41.84 | 24.24 | 7.89 | 8.00 |
Average Payables |
46.50 | 45.15 | 113.78 | 140.59 | 56.35 | 11.77 | 13.42 | 7.82 | 4.00 | 4.00 |
Average Inventory |
78.48 | 66.52 | 56.77 | 41.14 | 26.70 | 18.95 | 12.16 | 8.21 | 5.14 | 5.00 |
Average Assets |
1,749.63 | 1,636.02 | 1,698.20 | 1,907.24 | 2,238.14 | 1,617.16 | 774.97 | 465.17 | 171.47 | 171.50 |
Average Common Equity |
(119.48) | 9.52 | 109.43 | 352.59 | 971.75 | 1,048.44 | 640.77 | 145.89 | (145.68) | (145.50) |
Columns are period end dates